# Cluster Analysis: Globular Anchors and Metabolic Effectors

## Cluster Members
- **DMD** (Dystrophin): Anisotropy = 1.32, Disorder = 0.18
- **IGF1R** (Insulin-like Growth Factor 1 Receptor): Anisotropy = 1.43, Disorder = 0.16

## Shared Properties
- **Structural Profile:** Both proteins exhibit low anisotropy (Mean = 1.37) and low disorder (Mean = 0.17), indicating they are stable, globular domains rather than extended mechanosensitive antennas or highly disordered hubs.
- **Pathway Tags:** Strongly enriched for 'Thermodynamic_Cost', 'Muscle', 'Mechanotransduction', and 'Cytoskeleton'.
- **System Role:** Rather than sensing initial mechanical strain, these stable globular structures likely act as robust physical effectors or anchors that integrate mechanical tension with metabolic output.

## Hypothesized Mechanical Role
Within the biological counter-curvature framework, these proteins act as **stable globular effectors**. They serve as stable anchors that transduce high-tension mechanical loads into metabolic and growth signaling. Specifically, DMD physically anchors the cytoskeleton to the extracellular matrix, while IGF1R acts as a stable metabolic receptor whose signaling is gated or potentiated by the localized tension supplied by the cytoskeletal network.

## Concrete Test
**Cell/Tissue/Phenotype Test:**
Perform an *in vitro* assay using primary human myoblasts cultured on a stretchable substrate. Apply cyclic uniaxial stretch to mimic mechanical loading.
- **Intervention:** Use CRISPR/Cas9 or RNAi to knockdown DMD (disrupting the mechanical anchor).
- **Measurement:** Quantify IGF1R downstream signaling activation (e.g., p-AKT to total AKT ratio) using Western blot, and compare it against wild-type control myoblasts under identical stretch conditions.
- **Expected Outcome:** If DMD acts as the requisite mechanical anchor for proper IGF1R signaling under load, the DMD-knockdown myoblasts will show significantly blunted mechanically-induced IGF1R pathway activation compared to controls.
